Dr Jaffar Khan (National Heart, Lung and Blood Institute, Washington, DC, US) discusses the latest results from the BASILICA trial and the prevention of coronary artery obstruction from TAVR.
Filmed on site at CRT 2019 by Radcliffe Cardiology
1. Why did you perform this feasibility study?
2. What was the study design and the endpoints?
3. What were your findings?
Videographer: Tom Green
Educational Lead: Liam O'Neill, Chief Operating Officer